Gründing, A.R.; Schneider, M.A.; Richtmann, S.; Kriegsmann, M.; Winter, H.; Martinez-Delgado, B.; Varona, S.; Liu, B.; DeLuca, D.S.; Held, J.;
et al. Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene. Cancers 2022, 14, 4454.
https://doi.org/10.3390/cancers14184454
AMA Style
Gründing AR, Schneider MA, Richtmann S, Kriegsmann M, Winter H, Martinez-Delgado B, Varona S, Liu B, DeLuca DS, Held J,
et al. Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene. Cancers. 2022; 14(18):4454.
https://doi.org/10.3390/cancers14184454
Chicago/Turabian Style
Gründing, Anna Ricarda, Marc A. Schneider, Sarah Richtmann, Mark Kriegsmann, Hauke Winter, Beatriz Martinez-Delgado, Sarai Varona, Bin Liu, David S. DeLuca, Julia Held,
and et al. 2022. "Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene" Cancers 14, no. 18: 4454.
https://doi.org/10.3390/cancers14184454
APA Style
Gründing, A. R., Schneider, M. A., Richtmann, S., Kriegsmann, M., Winter, H., Martinez-Delgado, B., Varona, S., Liu, B., DeLuca, D. S., Held, J., Wrenger, S., Muley, T., Meister, M., Welte, T., & Janciauskiene, S.
(2022). Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene. Cancers, 14(18), 4454.
https://doi.org/10.3390/cancers14184454